Your 10/15 Profile: This
$2+ Biotech Idea Could Erupt
3 Previous Alerts Cruise
Full *PHBI* Report Below
Now is the time to turn full attention to my new alert,
(Ticker: PHBI). PHBI closed in the approximate range of $2.00 -
according to level 2
Have you been locked in on my recent profiles? If you haven't,
check out what you missed:
- BEGI -
Opened at $.07, ran to $.40. (
- ESYL -
(Opened at $.0045, ran to $.09) (
- CLTH -
(Opened at $.008, ran to $.079) (
We're looking at
%potential gains in
ONLY 3 PROFILES!
Is it getting hot in here,
or is it just me?
After you read the report on your new profile (below), you could be
running for the thermostat to crank that AC.
Why? Because it could end up being a
That's why I want to bring your attention to new breakout profile
for Tuesday, October 15th:
Pharmagreen Biotech Inc. (PHBI)
This next part is important... PHBI's current float needs a moment
of your time.
Like your last 3 breakout profiles above, there are only a
minuscule amount of available shares (
under 650K- OTC
Markets) on the market at this moment.
Volatilitycould be at a
high for PHBI Tuesday. If momentum and above average trading hit
this profile, price spiking could be in the cards in a major
You'll want to be watching
Rated as my
umber #1 Biotech
profile, you'll want to have your complete focus on PHBI today
for these reasons and more...
Pharmagreen is a
with specialized products and services in the can*nab*is (CB)
KEY DETAIL- The
Pharmagreen Botany Centre is dedicated to breaking boundaries to
become the most internationally recognized and valued biotech
science solutions company in North America for its proprietary
micro-propagation techniques, tissue culture plantlets production,
research and development for plants sustainability, preservation of
genetics, extraction of botanical oils, CB products development and
plant DNA species identification and certification center.
To wrap it up and put a bow on it, Pharmagreen is a
science driven and backed
companythat views their produced products as
Pharmagreen's model is to provide the hemp farmers the highest
quality starter female plantlets to produce the highest quality
biomass for the production of CB formulations for human and animal
Pharmagreen's ability to supply high CB starter plantlets paired
with high level of expertise in farming the strain provides a very
lucrative, high CB hemp farming opp. for farmers by making highly
efficient use of land.
Now, here's the best part...
revenue and higher yields can be generated from 10 acres with
Pharmagreen's high CB strain and farming techniques than from
farming 1,000 acres using standard industrial hemp from seed.
If you just scanned that last paragraph, you need to go back. That
info is bonkers!
By the way, did you know: The global industrial hemp market is
projected to grow from
$4.6BnUSD in 2019 to
$26.6BnUSD by 2025,
recording a CAGR of
With that type of growth potential in the global industrial hemp
market, wouldn't farmers looking to produce CB from hemp want to
and product quality while
minimizingthe amount of
land they use for their crops?
If you said no to that question, you might need
have your head
That's why I think that PHBI is currently flying under-the-radar
and could be the next big breakout idea within the "
PHBI Services Provide Clear
Picture For Market Domination
PLANT TISSUE CULTURE
CHIBAFREEN™ a new, highly evolved, state-of-the art in vitro plant
production method is introduced by the company Botanical Research
In Motion Inc. (B.R.I.M.) for exclusive use by WFS Pharmagreen Inc.
for various kinds of high quality transplant production in the
company’s Botany Center.
This proprietary process was developed by Dr. Fawzia Afreen.
In this method relatively small chlorophyllous (leafy) explants or
single nodal cuttings are grown inside the culture vessel under
pathogen free, sterile condition under artificial light.
The conventional in vitro system for transplant production involves
1) Initiation, 2) Multiplication, 3) Rooting and 4) Hardening.
In their new method one of the stages is eliminated, which reduce
the production period and costs drastically. The root formation and
the hardening of the plant are carried out using their new
technology, coined as Chibafreen™ in vitro plant production. The CB
Botany Center will produce approximately 10Mn plantlets at full
DNA TESTING SERVICES
Using DNA testing, growers can ensure they have the right genetics
of plants to grow:
their crops from uncertified plant species investment mitigate the
risk of plant to yield ratios
losses from environmental conditions
them from any financial damage
No other DNA commercial facility is in operation west of
Saskatchewan Research Council (SRC’s ) Biotechnology Laboratories
exists for scientific purposes only. B.R.I.M. will use SSR marker
(Simple sequence repeat) technology to fingerprint varieties. We
will develop an extensive database for several crops.
Clients/growers simply need to collect leaf samples (300 – 500 g)
of a suspect variety and our lab will compare its SSR fingerprint
to varieties in our database. These services will be provided by
B.R.I.M. as a value-added service for Pharmagreen’s Botany
COLD STORAGE UNIT
Lowering temperature can slow the metabolic processes (e.g.
respiration) and prevent undesirable loss of dry mass and
associated deteriorations of quality. The proper combination of air
temperature, light intensity and propriety techniques during
storage would contribute to minimizing increase/decrease in dry
weight and preserving photosynthetic ability and provide immediate
regrowth of plantlets after storage.
First of its kind service for:
preserve clients plants strains and propagate them when
maintain a variety of plants species indefinitely with the
immediate ability for mass reproduction.
production schedule on a commercial scale is possible.
Year-round greenhouse structures will be built on the property to
provide nursery service for CB plants inclusive of indica, sativa
and hemp strains for the CB cultivators. The company will be
working closely with industrial hemp farmers for the production of
hemp strains with high CB content. B.R.I.M. Inc. has completed
successful research on its high CB strain dubbed “CB DANA” which
content is well over 10% in CB and the THC at below .03% which
makes it ideal for industrial hemp farming.
“CB DANA” will be available for sale exclusively through
Pharmagreen’s CB Botany Center.
Extraction service for CB plant oils will be provided for all
clients as well as for future production of Pharmagreen brands of
CB products for human use. Additionally, B.R.I.M. will be
conducting research and development of CB formulations for
The extraction and distillation equipment will be certified medical
grade equipment with a capacity for commercial scale
Top TwoCatalysts To
Potentially Launch PHBI
Pharmagreen Biotech is
Seeking to Revolutionize Cancer Research and More with Their Botany
The CB industry is worth billions, and is showing no signs of
slowing down with many CB related companies now providing
crowdfunding investment opp's to both accredited and non-accredited
inve*stors who wish to participate in its growth. It may also help
discover cures and treatments for cancer. Pharmagreen Biotech, with
their S1 document now effective from the SEC, is one such company
targeting cancer research and much more with their vision of
multi-purpose CB Botany Centers.
Pharmagreen Signs a LOI for
Supply of CB Dana Hemp Starter Plantlets
Pharmagreen Biotech, Inc. is pleased to announce that its Canadian
subsidiary, WFS Pharmagreen Inc., has signed a Letter of Intent
with Carpere Inc. for the supply of “CB Dana” hemp starter
plantlets for the 2020 farming season and beyond.
The Pharmagreen team is excited to work with Carpere to be their
supplier of all female high CB hemp starter plantlets to produce
the highest quality high CB flower tops as well as production of
the CB whole hemp oils and isolate. Carpere owns and manages
farmland, on behalf of farmers, in excess of 100,000 acres